DLAT antibody (AA 169-273)
Quick Overview for DLAT antibody (AA 169-273) (ABIN7113485)
Target
See all DLAT AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 169-273
-
Purpose
- DLAT antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
-
Immunogen sequence: 169-273aa
Immunogen: dihydrolipoamide S-acetyltransferase
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:3000, IF : 1:10-1:100, IHC: 1:50 - 1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- DLAT (Dihydrolipoyl Transacetylase (DLAT))
-
Alternative Name
- DLAT
-
Background
-
Synonyms: Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial|70 kDa mitochondrial autoantigen of primary biliary cirrhosis (PBC)|Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex|M2 antigen complex 70 kDa subunit|Pyruvate dehydrogenase complex component E2 (PDC-E2, PDCE2)|DLAT|DLTA
Background: The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle.
-
Molecular Weight
- 70 kDa
-
Gene ID
- 1737
-
UniProt
- P10515
Target
-